Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

(2009) Shigeru Satoh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Role of Pharmacogenetics of Immunosuppressive Drugs in Organ Transplantation

(2009) Eric Thervet et al.   THERAPEUTIC DRUG MONITORING

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

(2009) Pierre Wallemacq et al.   THERAPEUTIC DRUG MONITORING

Extensions to the Visual Predictive Check to facilitate model performance evaluation

(2008) Teun M. Post et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

(2008) Dennis A. Hesselink et al.   Pharmacogenetics and Genomics

Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients

(2008) Nasirul J Ekbal et al.   PHARMACOGENOMICS

Maturation of Dose-Corrected Tacrolimus Predose Trough Levels in Pediatric Kidney Allograft Recipients

(2008) Maarten Naesens et al.   TRANSPLANTATION

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology

Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients

(2007) Joshua Y. Kausman et al.   PEDIATRIC TRANSPLANTATION